You are here

  • Home
  • Archive
  • Volume 2, Issue 1
  • Diabetes care and outcomes for American Indians and Alaska natives in commercial integrated delivery systems: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) Study

Article Text

Article menu
XML
Epidemiology/Health service research
Diabetes care and outcomes for American Indians and Alaska natives in commercial integrated delivery systems: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) Study
  1. Julie A Schmittdiel1,
  2. John F Steiner2,
  3. Alyce S Adams1,
  4. Wendy Dyer1,
  5. Janette Beals3,
  6. William G Henderson3,
  7. Jay Desai4,
  8. Leo S Morales5,
  9. Gregory A Nichols6,
  10. Jean M Lawrence7,
  11. Beth Waitzfelder8,
  12. Melissa G Butler9,
  13. Ram D Pathak10,
  14. Richard F Hamman3,
  15. Spero M Manson3
  1. 1Division of Research, Kaiser Permanente Northern California, Oakland, California, USA
  2. 2Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado, USA
  3. 3Centers for American Indian and Alaska Native Health, Colorado School of Public Health, University of Colorado Denver, Denver, Colorado, USA
  4. 4HealthPartners Institute for Education and Research, Minneapolis, Minnesota, USA
  5. 5Group Health Research Institute, Seattle, Washington, USA
  6. 6Kaiser Permanente Center for Health Research, Portland, Oregon, USA
  7. 7Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA
  8. 8Kaiser Permanente Hawaii, Honolulu, Hawaii, USA
  9. 9Kaiser Permanente Georgia Center for Health Research-Southeast, Atlanta, Georgia, USA
  10. 10Marshfield Clinic
  1. Correspondence to Julie Schmittdiel; Julie.A.Schmittdiel{at}kp.org

Abstract

Objective To compare cardiovascular disease risk factor testing rates and intermediate outcomes of care between American Indian/Alaska Native (AI/AN) patients with diabetes and non-Hispanic Caucasians enrolled in nine commercial integrated delivery systems in the USA.

Research design and methods We used modified Poisson regression models to compare the annual testing rates and risk factor control levels for glycated haemoglobin (HbA1c), low-density lipoprotein cholesterol (LDL-C), and systolic blood pressure (SBP); number of unique diabetes drug classes; insulin use; and oral diabetes drug medication adherence between insured AI/AN and non-Hispanic white adults with diabetes aged ≥18 in 2011.

Results 5831 AI/AN patients (1.8% of the cohort) met inclusion criteria. After adjusting for age, gender, comorbidities, insulin use, and geocoded socioeconomic status, AI/AN patients had similar rates of annual HbA1c, LDL-C, and SBP testing, and LDL-C and SBP control, compared with non-Hispanic Caucasians. However, AI/AN patients were significantly more likely to have HbA1c >9% (>74.9 mmol/mol; RR=1.47, 95% CI 1.38 to 1.58), and significantly less likely to adhere to their oral diabetes medications (RR=0.90, 95% CI 0.88 to 0.93) compared with non-Hispanic Caucasians.

Conclusions AI/AN patients in commercial integrated delivery systems have similar blood pressure and cholesterol testing and control, but significantly lower rates of HbA1c control and diabetes medication adherence, compared with non-Hispanic Caucasians. As more AI/ANs move to urban and suburban settings, clinicians and health plans should focus on addressing disparities in diabetes care and outcomes in this population.

  • American Indian(s)
  • Health Care Delivery

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

https://doi.org/10.1136/bmjdrc-2014-000043

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Supplementary materials

    • Supplementary Data

      This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

      Files in this Data Supplement: